Zhenjian Xu
Overview
Explore the profile of Zhenjian Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Q, Zhang X, Yang H, Luo G, Zhou X, Xu Z, et al.
Apoptosis
. 2024 Jul;
29(9-10):1709-1722.
PMID: 39068624
The occurrence of acute kidney injury (AKI) is elevated, one of the main causes is ischemia-reperfusion (I/R). However, no specific therapy is currently available to treat I/R-induced AKI (I/R-AKI). Treg...
2.
Xu Z, Zhou X, Yang H, Chen Q, Luo G, Cai S, et al.
Clin Nephrol
. 2024 Mar;
101(6):263-270.
PMID: 38497685
Purpose: Acute kidney injury (AKI) is a common early complication secondary to transcatheter aortic valve replacement (TAVR). Studies on the incidence and risk factors for AKI after TAVR surgery are...
3.
Fu S, Xu Z, Lin B, Chen J, Huang Q, Xu Y, et al.
Front Med (Lausanne)
. 2021 Jul;
8:657067.
PMID: 34235161
The effect of the angiotensin receptor-neprilysin inhibitor (ARNI) sacubitril-valsartan in patients with heart failure with preserved ejection fraction (HFpEF) remains unclear, and data on ARNI treatment in peritoneal dialysis (PD)...
4.
Xu Z, Tang Y, Huang Q, Fu S, Li X, Lin B, et al.
BMC Nephrol
. 2021 Feb;
22(1):52.
PMID: 33546616
Background: Acute kidney injury (AKI) occurs among patients with coronavirus disease-19 (COVID-19) and has also been indicated to be associated with in-hospital mortality. Remdesivir has been authorized for the treatment...
5.
Xu Z, Chen J, Yu W, Li X, Lin B, Lai D, et al.
Postgrad Med J
. 2020 Oct;
98(1155):13-17.
PMID: 33087535
Purpose: IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis and a leading cause of chronic kidney disease (CKD) and end-stage kidney disease (ESKD). Recently, some case reports...
6.
Liao W, Liang P, Liu B, Xu Z, Zhang L, Feng M, et al.
Front Physiol
. 2020 Oct;
11:1093.
PMID: 33013464
Renal tubulointerstitial fibrosis is usually the final outcome of various end-stage renal diseases. Recent studies have reported that microRNAs (miRNAs) play an important role in renal fibrosis. However, the biological...
7.
Chen Y, Xu Z, Liang R, Wang J, Xu A, Na N, et al.
Mol Ther
. 2020 Aug;
28(11):2406-2416.
PMID: 32738192
CD4Foxp3 regulatory T (Treg) cells are crucial for maintaining homeostasis and preventing autoimmune diseases. Nonetheless, we and others have previously reported that natural Treg cells are unstable and dysfunctional in...
8.
Fu S, Chen J, Liu B, Liang P, Zeng Y, Feng M, et al.
BMC Nephrol
. 2020 Jun;
21(1):237.
PMID: 32576274
Background: This study aimed to ascertain whether the correlation of high serum ferritin with mortality is affected by systemic inflammation and to investigate the optimal serum ferritin level for predicting...
9.
Dang J, Xu Z, Xu A, Liu Y, Fu Q, Wang J, et al.
J Autoimmun
. 2020 Jun;
113:102491.
PMID: 32565049
Cell specific and cytokine targeted therapeutics have underperformed in systemic lupus erythematosus (SLE). Mesenchymal stem cells (MSCs) have emerged as a novel therapy to address the dysregulation in autoimmune diseases...
10.
Yang Y, Ma L, Huang J, Gu C, Xu Z, Liu J, et al.
Materials (Basel)
. 2019 Nov;
12(22).
PMID: 31717274
The early age volume deformation is the main course for the cracking of high-performance concrete (HPC). Hence, the shrinkage behavior and the restrained stress development of HPC under different restraints...